https://doi.org/10.4081/aiua.2025.13848
Metastatic cancer to the penis: a multi-institutional comprehensive analysis of 31 patients
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 19 May 2025
Introduction: The metastatic spread of cancer to the penis is a very rare clinical entity generally associated with disseminated disease and poor prognosis. The aim of this paper was to show the outcomes of a series of patients treated for metastatic cancer to the penis and enhance the understanding and the management of penile metastasis in order to improve patients’ care and outcomes.
Methods: We retrospectively analyzed the medical records of 31 patients diagnosed with metastatic cancer to the penis and treated at eight Ligurian urological departments between January 2014 and January 2024. Clinical characteristics, physical examination findings, diagnostic evaluations, treatment options and follow-up data were assessed.
Results: 27 (87%) patients had a prior history of malignancy with a metachronous metastasis. The most common primary site of malignancy was the genitourinary tract (71.1%) followed by the gastrointestinal tract (16.1%). The time interval from the diagnosis of the primary tumour to the detection of the penile metastasis was 36.0 months. The penile metastasis generally appeared with a mass (54.8%) and pain (29%), more rarely with priapism (6.5%), oedema (6.5%) and hematuria/urinary disorders (3.2%). The metastatic lesion required a total penectomy in 17 (54.8%) patients and a partial penectomy in 8 patients (25.8%). At a follow-up of 15.9 (1-75) months, 4 (18.2%) patients were still alive with disease.
Conclusions: Our data confirmed penile metastasis as a rare entity usually associated with clinical symptoms involving the penis in the context of a known primary malignancy, mainly from the neighboring pelvic organs, with a poor prognosis. The majority of our patients required a total penectomy with a negative impact on their quality of life. These aspects highlighted the importance of a penile examination and an early diagnosis of a penile metastasis during the follow-up schedule of many patients with a history of previous oncologic disease.
Downloads
Cocci A, Hakenberg OW, Cai T, et al. Prognosis of men with penile metastasis and malignant priapism: a systematic review. Oncotarget 2018; 9:2923-30. DOI: https://doi.org/10.18632/oncotarget.23366
Zhang K, Da J, Yao H jun, et al. Metastatic tumors of the penis: a report of 8 cases and review of the literature. Medicine (Baltimore) 2015; 94:e132. DOI: https://doi.org/10.1097/MD.0000000000000132
De Rose AF, Vecco F, Gallo F, et al. Penile metastasis of colorectal cancer; case report and discussion on this rare clinical entity. Ann Case Rep. 2023; 8:1-4. DOI: https://doi.org/10.29011/2574-7754.101414
Zou Q, Jiao J, Zou M hong, et al. Diffuse metastases in bilateral penile corpus cavernosum from renal cancer diagnosed by 18FFDG PET/CT. Clin Nucl Med. 2020;45:451-2. DOI: https://doi.org/10.1097/RLU.0000000000002988
Guo LC, Li G, Wang XM, et al. Penile metastases from primary lung cancer: Case report and literature review. Medicine (Baltimore) 2017; 96:e7307. DOI: https://doi.org/10.1097/MD.0000000000007307
Maruyama Y, Sadahira T, Mitsui Y, et al. Red nodular melanoma of the penile foreskin: A case report and literature review. Mol Clin Oncol. 2018; 9:449-452. DOI: https://doi.org/10.3892/mco.2018.1697
Mearini L, Colella R, Zucchi A, et al. A review of penile metastasis. Oncol Rev. 2012; 6:e10. DOI: https://doi.org/10.4081/oncol.2012.e10
Nova-Camacho LM, Acosta AM, Trpkov K, et al. Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an international collaboration. Hum Pathol. 2023; 139:37-46. DOI: https://doi.org/10.1016/j.humpath.2023.06.002
Cherian J, Rajan S, Thwaini A, et al. Secondary penile tumours revisited. Int. Semin. Surg. Oncol 2006; 3:33. DOI: https://doi.org/10.1186/1477-7800-3-33
Dust N, Bates AW, Baithun SI. Secondary neoplasms of the male genital tract with different patterns of involvement in adults and children. Histopathology 2000;37:323-331. DOI: https://doi.org/10.1046/j.1365-2559.2000.00983.x
Morichetti D, Mazzucchelli R, Lopez-Beltran A, et al. Secondary neoplasms of the urinary system and male genital organs. BJU Int. 2009; 104:770-776. DOI: https://doi.org/10.1111/j.1464-410X.2009.08746.x
Hizli F, Berkmen F. Penile metastasis from other malignancies. A study of ten cases and review of the literature. Urol Int. 2006; 76:118-121. DOI: https://doi.org/10.1159/000090872
Chaux A, Amin M, Cubilla AL, et al. Metastatic tumors to the penis: a report of 17 cases and review of the literature. Int J Surg Pathol. 2011; 19:597-606. DOI: https://doi.org/10.1177/1066896909350468
Eberth CJ. Krebsmetastasen des Corpus cavernosum penis. Archiv Pathol Anat 1870;51: 145-146. DOI: https://doi.org/10.1007/BF01879422
Giunchi F, Vasuri F, Valerio V, et al. Unusual asymptomatic presentation of bladder cancer metastatic to the penis. Pathol. Res. Pract. 2017;213:717-720. DOI: https://doi.org/10.1016/j.prp.2016.11.019
Ellis CL, Epstein JI. Metastatic prostate adenocarcinoma to the penis: A series of 29 cases with predilection for ductal adeno- carcinoma. Am. J. Surg. Pathol. 2015;39:67-74. DOI: https://doi.org/10.1097/PAS.0000000000000289
De Rose AF, Mantica G, Gallo F, et al. Risk factors for the delay in the diagnosis of penile lesions: results from a single center in Italy. Minerva Urol Nefrol. 2019;71:258-263. DOI: https://doi.org/10.23736/S0393-2249.18.03189-2
Brouwer OR, Albersen M, Parnham A, et al. European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update. Eur Urol. 2023; 83:548-560. DOI: https://doi.org/10.1016/j.eururo.2023.02.027
Simon N, Atiq S, Sonpavde G, et al. New therapeutic horizons for advanced or metastatic penile cancer. Urol Clin North Am. 2024; 51:367-376. DOI: https://doi.org/10.1016/j.ucl.2024.03.005
Croghan SM, Cullen IM, Raheem O. Functional outcomes and health-related quality of life following penile cancer surgery: a comprehensive review. Sex Med Rev. 2023; 11:441-459. DOI: https://doi.org/10.1093/sxmrev/qead021
Pérez J, Chavarriaga J, Ortiz A, et al. Oncological and functional outcomes after organ-sparing plastic reconstructive surgery for penile cancer. Urology. 2020;142:161-165. DOI: https://doi.org/10.1016/j.urology.2020.03.058
Croghan SM, Compton N, Daniels AE, et al. Phallus preservation in penile cancer surgery: patient-reported aesthetic & functional outcomes. Urology. 2021;152:60-66. DOI: https://doi.org/10.1016/j.urology.2021.02.011
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.